temozolomide,talazoparib
pfizer
['temozolomide', 'biomarker', 'talazoparib']
#asco22 abstract #8517 by dr. jon goldman explores talazoparib (#parp) + temozolomide. rr 39%, mpfs 4.5m, mos 11.9m. prior studies have shown similar trends but going forward, need to define optimal dose (and possibly identify proper biomarker). 
Director of Thoracic Oncology & Developmental Therapeutics @LombardiCancer, Associate Professor @Georgetown University #LCSM #HereWeGo #ITYSL He/Him